Introduction
ain is an inseparable part of human's life that has a key protective role (Vranken, 2014) . Persistent pain can change the central and peripheral nervous system through neuroplasticity phenomenon and peripheral and central sensitization (Paknejad, Asghari, Rahiminezhad, Rostami, & Taheri, 2014) . According to "International Association for the Study of Pain" definition, pain is an unpleasant sensory or emotional experience caused by actual or potential harm and has two dimensions of sensory and emotional. The sensory dimension refers to the severity of pain and its emotional dimension to the unpleasantness experienced by the individual. Pain is divided into two groups in terms of temporal profile, including acute (lasts less than three months) and chronic (persists for at least three months) (Gharaei, Azadfallah, & Tavallaei, 2012) .
In the classification of chronic pain, headache is a common complaint (Kristoffersen, Grande, Aaseth, Lundqvist, & Russell, 2012) . It is one of the most common complaints in neurology clinics (Behrouz, Amini, Abedi, & Ghasemi, 2013; Kachoei, Amelly, Sharifibonnab, Tavallaei, & Keshavarzi, 2009; Kurt & Kaplan, 2008) .
According to the International Classification of Headache Disorders; 3rd edition -Beta version (ICHD-βIII), chronic headache refers to a headache that lasts more than 15 days per month and more than three months (Ashjazadeh & Jowkar, 2015; Mirzaei, Khorvash, Ghasemi, Memar-Montazerin, & Khazaeili, 2016; Naderinabi et al., 2017; Saberi, Roudbary, Elyasi, & Kazemnejad Leyli, 2013) . According to the International Headache Society (IHS) classification, headache includes two types of primary and secondary. The present study examined primary chronic headache (0Naderinabi et al., 2017; Saberi, Nemati, Shakib, Kazemnejad, & Maleki, 2012) .
Frequent and severe headaches can impress the quality of life (Behrouz et al., 2013; Kurt & Kaplan, 2008) . Depression and especially anxiety have a greater chance of comorbidity with migraine headache, and these two symptoms significantly contribute to the overuse of medications for relieving headache. Researchers conclude that better outcomes can be accomplished in patients with headache through screening anxiety and depression and controlling them Mirzaei et al., 2016; Zebenholzer et al., 2016) . Since depression and anxiety have a dramatic effect on the quality of life of patients with headache and increase the cost of care, multidimensional approaches to treat headache is mandatory for decreasing personal, occupational, and social disabilities in patients with headache (Zebenholzer et al., 2016) .
Depression and anxiety symptoms are highly prevalent among Iranian patients with headache. Chitsaz et al., concluded that the likelihood of developing headache is 2.35 times higher in people with moderate depression, 2.67 times higher in patients with moderate anxiety, and 2.7 times higher in patients with severe anxiety than the ones with none of these symptoms (Chitsaz & Ghorbani, 2005) .
Plain Language Summary
Chronic headache refers to a headache that lasts more than 15 days per month for at least 3 months. It is classified into 2 types of primary and secondary. Self-efficacy refers to an individual's belief in his or her capacity to do necessary behaviors to produce specific performance attainments. It is one of the psychological factors with modifying effects on the level of pain experienced by the individual. Previous studies indicate that pain self-efficacy can reduce pain, anxiety, depression, and other complications associated with chronic disorders. High levels of pain self-efficacy beliefs are associated with reduced severity of pain, and fewer symptoms of anxiety and even its moderate to high levels are associated with a reduction of attacks frequency. Teaching such beliefs may, therefore, affect the severity and frequency of headache.
The researchers recommend that the comorbid psychological aspects of headache should also be assessed for the diagnosis, prognosis, and treatment of chronic headaches. Self-efficacy is one of the psychological factors with modifying effects on the level of pain experienced by the individual (Rezaei, Afsharnejad, Moosavi, Yousefzadeh, & Soltani, 2012) . According to Bandura's theory of social learning, self-efficacy refers to the individual's feeling of confidence in own ability to achieve a desired outcome. This construct determines the individual's amount of effort and persistence in overcoming irritating problems and experiences (Bandura, 1977) . This concept is the individual's degree of confidence in own ability to maintain functioning in spite of pain (Arnstein, Caudill, Mandle, Norris, & Beasley, 1999; Jensen, Turner, & Romano, 1991; Marks & Allegrante, 2005; Rezaei et al., 2012) . Generally, a higher self-efficacy helps to promote and preserve the desirable effects of rehabilitation and contributes to the use of pain coping strategies, pain and disability control, adaptive psychological functioning and desirable treatment outcomes in patients with chronic pain (Rezaei et al., 2012) .
In one study, Kalapurakkel et al.,(Kalapurakkel, Carpino, Lebel, & Simons, 2014) found that pain self-efficacy and acceptance of the reality of pain are associated with reduced disability, improved academic performance, and fewer depression symptoms. In another study, Carpino et al., (Carpino, Segal, Logan, Lebel, & Simons, 2014) found that pain self-efficacy improves functional ability and academic performance in adolescents with headache by reducing pain-related fear. They also suggested that promoting pain self-efficacy beliefs can be a key mechanism for improving behavioral outcomes.
The prevalence of headache is very high (Bahrami, Zebardast, Zibaei, Mohammadzadeh, & Zabandan, 2012) and imposes huge burden to community health systems (Börsbo, Gerdle, & Peolsson, 2010) . On the other hand for treating the pain especially chronic pain, prescription of pain killers has many side effects mostly on gastrointestinal system. The evidence suggests that NSAIDs used as pain killer drugs increase the risk of lower GI bleeding and perforation to a similar extent observed in the upper GI tract. Newer treatment including selective cyclooxygenase-2 inhibitors are introduced with the same beneficial effects as nonselective NSAIDs with less GI toxicity in the upper GI tract and probably in the lower GI tract. Also, overall mortality due to these complications is also decreased, but the in-hospital case fatality for upper and lower GI complication events is constant despite the new therapeutic and preventive strategies (Sostres, Gargallo, & Lanas, 2013) . Therefore, it is essential to use other treatment methods to avoid the complications of pain relief drugs and improve the quality of life of patients.
Previous studies show that pain self-efficacy can have a role in reducing pain, anxiety, depression and other complications associated with chronic disorders (Börsbo, Gerdle, & Peolsson, 2010; French et al., 2000; Hellström, Vahlberg, Urell, & Emtner, 2009; Rezaei et al., 2012; Tahmassian & Moghadam, 2011; Wu et al., 2013) . Also some findings suggest that clinician-conveyed expectations can enhance the benefit of treatments mediated by improved patient self-efficacy (Lo, Balasubramanyam, Barbo, Street, & Suarez-Almazor, 2016) . But these studies did not focus on headache especially chronic headache, also such studies are not yet extensively carried out in the highly-populated communities. Therefor the present study aimed at answering the question of whether there is a relationship between self-efficacy beliefs and psychological symptoms and clinical outcomes in patients with headache irrespective of demographic and background differences.
Methods
The present descriptive cross-sectional study was conducted on patients with primary chronic headache selected through consecutive sampling. It is a sampling technique in which every subject meeting the criteria of inclusion is selected until the required sample size is achieved (Polit & Beck, 2009 ). The statistical population included all patients with chronic primary headache referred to neurology clinics of Guilan University of Medical Sciences from September 2016 to March 2017. The sample size was determined 98 subjects in accordance with the F ratio for a maximum of five variables entered into the prediction block (1 pain self-efficacy variable and 5 covariate variables, including age, gender, education, marital status and associated illness) using G×Power 3.1.9.2 (Faul, Erdfelder, Buchner, & Lang, 2009 ) and taking into account a probability of type-1 error (alpha) of 0.05 (95% confidence interval), accep table test power of 0.8 and medium effect size of f2=0.15. It was increased to 107 to manage the outliers and the unsuccessful completion of tests for 10% dropout.
Inclusion criteria: Meeting the criteria for primary chronic headache and referring to the neurology clinics of Guilan University of Medical Sciences from September 2016 to March 2017.
Exclusion criteria: Unwillingness to participate in study, poor cooperation, inability to respond to the ex-aminer's questions due to the severity of pain, acute headache, secondary chronic headaches as diagnosed by the IHS criteria and a neurologist.
Procedure
Following the diagnosis made by a neurologist, irrespective of their demographic and professional characteristics, the candidate patients were referred to a trained examiner in another room in the same clinic to talk about participation in the study and briefing on the confidentiality of their data and submiting their informed consent. The patients unable to talk at that time for any reason or the ones with a headache attack that distracted them from understanding the test items were asked to refer for an interview and assessment on a later time when the examiner and specialist were both present and the disturbing conditions had subsided.
For the assessment, the patients' demographic and background variables (including age, gender, education, occupation and marital status) were collected using a researcher-made checklist. The patients were also asked about the frequency of their headache attacks (per month), the mean duration of their headache from the onset of the first attack (in month) and the mean duration of each headache attack (in hour). The mean severity of the headache often experienced by each patient was then measured using the VAS. All the patients were then asked to answer the Pain Self-Efficacy Scale and the Hospital Anxiety and Depression Scale (HADS) according to the given instructions. All procedures performed in the present study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with those of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The current article does not contain any studies on animals, and the authors declare that they have no conflict of interest. Informed consent was obtained from all individual participants included in the study.
Tools
The Visual Analogue Scale (VAS) for the severity of pain: A horizontal 100-mm line was used for the Visual Analog Scale (VAS), anchored with 'no pain' (0) and 'worst pain' (100). It was developed by Huskisson (1974) and Participants marked their level of pain 'right now' on this line with a slash. The reliability and validity of the VAS as a measure of pain is established in multiple, diverse populations (Seymour, 1982) . The Pain Self-Efficacy Scale: The current study employed the 6-item Self-Efficacy for Managing Chronic Disease Scale developed and standardized at the Center for Epidemiological Studies of Stanford University by Lorig et al.,. Each item is scored from 0 for "Not at All Confident" to 10 for "Totally Confident" and higher scores indicate higher self-efficacy. Its internal consistency is reported 0.91 (Lorig, Chastain, Ung, Shoor, & Holman, 1989) . The Persian version of this scale was validated in a population of patients with chronic pain and its internal consistency was reported with a Cronbach's alpha of 0.87 and its test-retest reliability with a two-week interval was reported as 0.73. Also, the two measurements did not show any significant differences.
The factor structure of the scale was assessed using the exploratory factor analysis and the results showed that the six items of the scale were loaded on one factor, namely pain self-efficacy. To assign the construct and criterion validity of the scale using hierarchical regression analysis, its scores significantly predicted the variance in the scores of the "fear of movement", "depression", "disability" and "coping strategies" tests, even when the confounding effects of age, severity, and duration of pain and duration of medication use were controlled (Rezaei et al., 2012) .
The Hospital Anxiety and Depression Scale (HADS): This 14-item self-reporting scale (with seven items on depression and seven on anxiety) is designed to screen the presence and severity of depression and anxiety symptoms. Its completion takes less than five minutes, and assesses the subjects aged 16 and above (Kaviani, Seyfourian, Sharifi, & Ebrahimkhani, 2009; McCue, Buchanan, & Martin, 2006) . Physical symptoms are eliminated from the scale to reduce the false positive diagnosis. Each item is scored from 0 to 3 and the total score for each subscale (depression and anxiety) ranges from 0 to 21, and higher scores indicate severer symptoms. The internal consistency was confirmed with a Cronbach's alpha of 0.89 for the anxiety subscale and 0.85 for the depression subscale, and the construct validity of the scale was deemed satisfactory using relevant scales (Kaviani et al., 2009 ).
Statistical analysis
The collected data were encoded and then analyzed with SPSS V. 20, and the relationship between the variables was determined using the Pearson correlation coefficient and Spearman's correlation coefficient (rho). The difference between the male and female groups of patients was determined using the independent student t-test, and Mann-Whitney's U-test was used to compare the ordinal mean of the variables for the non-normallydistributed data (based on the Kolmogorov-Smirnov test). The hierarchical multivariate regression analysis was used to determine whether, after controlling the demographic variables, the self-efficacy belief scores could predict the patients' scores of headache, depression, and anxiety. Before performing this analysis, the assumption of the normal distribution of the criterion variable in the regression analysis and the assumption of the independence of the prediction errors and the absence of autocorrelation between the errors were verified.
Results
A total of 106 patients (22 males and 84 females) with a Mean±SD age of 38.46±13.33 years participated in the current study. The data of one patient was incomplete and was removed. Table 1 presents the frequency of the demographic details of the patients with headache and the frequency distribution of the different types of head-ache. Table 2 presents the mean and standard deviation of the demographic details and Pearson's and Spearman's correlation coefficients for the study variables.
Hypothyroidism was the most common comorbid condition of chronic headache (n=6.5%). The most common types of chronic headache in the participants included chronic tension headache (51.9%), chronic migraine headache (25.5%), and hemicrania continua (7.5%), in respective order.
The results presented in Table 2 showed an inverse significant relationship between self-efficacy beliefs and the severity of pain as per the VAS (r=-0.25, P=0.009), which means that the severity of pain reduced with increased pain self-efficacy beliefs. Nevertheless, no significant relationships were observed between self-efficacy beliefs and the other outcomes such as anxiety and depression (P>0.05). The analysis using Spearman's correlation coefficient (rho) showed no significant relationships be- The Kolmogorov-Smirnov test results showed that headache duration, headache frequency, and duration of headache attacks were not normally distributed; therefore, Mann-Whitney's U-test was used to determine the intergroup differences of these variables. Comparing the two groups of male and female patients and the two groups of patients with headache with and without an associated illness showed no differences in terms of the headache-related variables including the duration of headache (in month), the mean duration of each headache (in hour), the frequency and severity of headaches (based on the VAS) or the psychological variables (P>0.05). In addition, comparing the two groups of single and married patients only showed that the married patients had Before performing the regression analysis, the assumption of normality of the criterion variable in the regression analysis of the scores of the dependent variables (including headache duration, duration of headache attacks, frequency of headache attacks and levels of anxiety and depression) was assessed based on the independent variable (ie pain self-efficacy) using a normal P-P plot.
The normal P-P plots showed that the observed cumulative probability or points representing the standardized remainders of the criterion variables, with the exception of headache duration, duration of attacks and frequency of attacks were close to the normal line (which represents normal distribution); variables including the severity of pain, anxiety, and depression had a small deviation from normal distribution. In addition, given the statistical indices in Table 3 , the results of the Durbin-Watson (DW) test revealed that the assumption of the independence of the errors for the regression analysis held for every single dependent variable and was in the accep table range of 1.5-2.5. Table 3 shows the results of the hierarchical multivariate regression analysis before and after controlling the demographic variables. Table 3 showed that after eliminating the effect of the demographic variables, pain self-efficacy was able to predict the severity of pain (P=0.035, F=4.57) and anxiety (P=0.038, F=4.414) significantly. The Beta coefficients revealed that with each unit of increase in the standard deviation of the pain self-efficacy score, the scores of severity of pain (as per the VAS) and anxiety symptoms decreased by 0.206 and 0.209 units of standard deviation. The regression analysis could not significantly predict the depression scores. Since the P-P plot showed the deviation from normality in the three variables including headache duration, duration of headache attacks, and frequency of headache attacks, the curve estimation regression was used to predict their values based on the pain self-efficacy scores ( Table 4 ).
The results presented in Table 4 showed a significant non-linear quadratic relationship between pain self-efficacy and the frequency of headache attacks (P=0.038, F=3.377). Figure 1 presents this curved relationship; however, the quadratic relationship could not predict headache duration and the duration of headache attacks significantly from pain self-efficacy. Figure 1 showed a significant curved relationship between the mean frequency of headache attacks and pain self-efficacy (with its score on the X axis). According to this curve, the frequency of headache attacks reduced to its minimum as the scores of pain self-efficacy increased, especially in the 30 to 50 age range.
Discussion
The main finding of the correlation analysis was the inverse significant relationship between pain self-efficacy beliefs and the severity of pain. In other words, the severity of headache reduced as pain self-efficacy beliefs improved. Comparing the patients in terms of marital status showed that the married patients had more severe headaches compared to the single ones. This result is believed to be due to the older age of the married patients and also their widely different social, economic, physiological, and psychological factors; although these factors were not addressed in detail in the current study. Marital status and other demographic and background variables such as age, gender, education, and associated illnesses were controlled in the current study to answer the study questions using hierarchical regression analysis.
The hierarchical multivariate regression analysis showed that pain self-efficacy beliefs can predict the severity of pain and anxiety symptoms inversely and significantly. In line with the present findings, previous studies also showed an inverse significant relationship between self-efficacy and the severity of pain (Börsbo et al., 2010; Ferrari, Chiarotto, Pellizzer, Vanti, & Monticone, 2016; Martin, Holroyd, & Rokicki, 1993; Rezaei et al., 2012) .This result can be explained by noting that high levels of pain self-efficacy increase social and job functioning as well as pleasurable and beneficial activities. Additionally, pain self-efficacy is a high-level cognitive process that affects the individual's coping style and problem-solving in life and helps to keep away factors such as despair that fuel pain. People with poor selfefficacy tend to avoid barriers instead of dealing with them, do not make an effort, show very little resistance and persistence and surrender to pain and report severer pain in psychological tests.
As noted, poorer pain self-efficacy predicted higher levels of anxiety in the patients. This result was in agreement with the results obtained in previous studies (Martin et al., 1993; Tahmassian & Moghadam, 2011; Wu et al., 2013) . For example, French et al., (2000) (Marks & Allegrante, 2005) studied 329 patients seeking treatment for headache and found an inverse relationship between anxiety and pain self-efficacy or management. To explain this finding, it can be said that people that doubt their pain management abilities have a pessimistic evaluation of themselves due to these doubts and lose their ability to control pain and experience increased levels of anxiety. The onset of headache can adversely affect academic and job performances (Behrouz et al., 2013; Kurt & Kaplan, 2008; Zebenholzer et al., 2016) ; therefore, patients with poor pain self-efficacy may also experience anxiety due to their poor performances and the social consequences of failing at their job and academic duties and their accountability for them.
The present findings do not adequately support the protective role of pain self-efficacy in reducing depression in patients with headache. In disagreement with the present study, Wu et al., (2013) showed that in patients with type-II diabetes, pain self-efficacy was associated with reduced anxiety. Tahmassian et al., (2011) found that self-efficacy was an inverse determinant of depression. This disparity of findings is believed to be due to different samples and measurement tools used. In addition, the relationship between pain self-efficacy and depression in patients with headache seems to be affected by other neuropsychiatric factors not addressed in the present study.
Finally, the results of the curve estimation regression showed that pain self-efficacy did not predict headache duration or the duration of attacks, but a non-linear quadratic relationship was observed between pain selfefficacy and the frequency of headache attacks, which means that even moderate to high scores of pain self-efficacy are associated with the lowest frequency of headache attacks. A possible reason is that pain self-efficacy helps persons by employing psychological shock absorbers and increasing psychological capacities and the threshold for headache-inducing factors. Newer explanations among the Japanese patients with chronic pain (Karasawa et al., 2019) suggest that patients with high self-efficacy may have better outcomes and social survival in spite of severe and persistent pain. It is therefore understandable how better self-efficacy in the current study helps to reduce anxiety symptoms in patients with headache by maintaining and receiving social support. The assessment of the role of self-efficacy in management of pain helps the therapists and physicians to have an understanding of the ability to manage pain in their patients. Furthermore, physicians are advised to focus on self-efficacy in clinical practice, as its protective effect can reduce the symptoms of anxiety and the frequency of headache attacks. Future research should focus on the development of therapeutic strategies in patients with headache and using self-efficacy, since its beneficial effects in management of headache were identified in the current study as well as the other researches.
The strengths of this study include its uniform sample of patients with chronic headache; however, the results cannot be generalized to other groups of patients with chronic diseases or acute pain. The current was crosssectional and no cause and effect relationships can be inferred from its results. Some of the study variables did not have a normal distribution including headache duration, and duration and frequency of attacks, which limited the possibility of controlling the confounding variables. According to these limitations, future studies are recommended to use trial or interventional designs to test the hypothesis of whether teaching pain self-efficacy reduces the psychological symptoms and improves clinical outcomes of headache.
High levels of pain self-efficacy beliefs are associated with reduced severity of pain and fewer symptoms of anxiety and even its moderate to high levels are associated with reduction of attacks frequency. Teaching such beliefs may therefore have an effect on controlling the severity and frequency of headache.
